AAAAAA
Results:
1-23
|
Results: 23
Authors:
Van Vaerenbergh, K
Debaisieux, L
De Cabooter, N
Declercq, C
Desmet, K
Fransen, K
Maes, B
Marissens, D
Miller, K
Muyldermans, G
Sprecher, S
Stuyver, L
Vaira, D
Verhofstede, C
Zissis, G
Van Ranst, M
De Clercq, E
Desmyter, J
Vandamme, AM
Citation: K. Van Vaerenbergh et al., Prevalence of genotypic resistance among antiretroviral drug-naive HTV-1-infected patients in Belgium, ANTIVIR TH, 6(1), 2001, pp. 63-70
Authors:
Swenson, PD
Van Geyt, C
Alexander, ER
Hagan, H
Freitag-Koontz, JM
Wilson, S
Norder, H
Magnius, LO
Stuyver, L
Citation: Pd. Swenson et al., Hepatitis B virus genotypes and HBsAg subtypes in refugees and injection drug users in the United States determined by LiPA and monoclonal EIA, J MED VIROL, 64(3), 2001, pp. 299-304
Authors:
Swenson, PD
Van Geyt, C
Alexander, ER
Hagan, H
Freitag-Koontz, JM
Wilson, S
Norder, H
Magnius, LO
Stuyver, L
Citation: Pd. Swenson et al., Hepatitis B virus genotypes and HBsAg subtypes in refugees and injection drug users in the united states determined by LiPA and monoclonal EIA, J MED VIROL, 64(3), 2001, pp. 305-311
Authors:
Van Vaerenbergh, K
Van Laethem, K
Van Wijngaerden, E
Schmit, JC
Schneider, F
Ruiz, L
Clotet, B
Verhofstede, C
Van Wanzeele, F
Muyldermans, G
Simons, P
Stuyver, L
Hermans, P
Evans, C
De Clercq, E
Desmyter, J
Vandamme, AM
Citation: K. Van Vaerenbergh et al., Baseline HIV type 1 genotypic resistance to a newly added nucleoside analog is predictive of virologic failure of the new therapy, AIDS RES H, 16(6), 2000, pp. 529-537
Authors:
Ahmed, SNS
Tavan, D
Pichoud, C
Berby, F
Stuyver, L
Johnson, M
Merle, P
Abidi, H
Trepo, C
Zoulim, F
Citation: Sns. Ahmed et al., Early detection of viral resistance by determination of hepatitis B virus polymerase mutations in patients treated by lamivudine for chronic hepatitis B, HEPATOLOGY, 32(5), 2000, pp. 1078-1088
Authors:
Puig, T
Perez-Olmeda, M
Rubio, A
Ruiz, L
Briones, C
Franco, JM
Gomez-Cano, M
Stuyver, L
Zamora, L
Alvarez, C
Leal, M
Clotet, B
Soriano, V
Citation: T. Puig et al., Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain, AIDS, 14(6), 2000, pp. 727-732
Authors:
Grandjacques, C
Pradat, P
Stuyver, L
Chevallier, M
Chevallier, P
Pichoud, C
Maisonnas, M
Trepo, C
Zoulim, F
Citation: C. Grandjacques et al., Rapid detection of genotypes and mutations in the pre-core promoter and the pre-core region of hepatitis B virus genome: correlation with viral persistence and disease severity, J HEPATOL, 33(3), 2000, pp. 430-439
Authors:
Pichoud, C
Berby, F
Stuyver, L
Petit, MA
Trepo, C
Zoulim, F
Citation: C. Pichoud et al., Persistence of viral replication after anti-HBe seroconversion during antiviral therapy for chronic hepatitis B, J HEPATOL, 32(2), 2000, pp. 307-316
Authors:
Stuyver, L
Van Geyt, C
De Gendt, S
Van Reybroeck, G
Zoulim, F
Leroux-Roels, G
Rossau, R
Citation: L. Stuyver et al., Line probe assay for monitoring drug resistance in hepatitis B virus-infected patients during antiviral therapy, J CLIN MICR, 38(2), 2000, pp. 702-707
Authors:
Van Vaerenbergh, K
Van Laethem, K
Albert, J
Boucher, CAB
Clotet, B
Floridia, M
Gerstoft, J
Hejdeman, B
Nielsen, C
Pannecouque, C
Perrin, L
Pirillo, MF
Ruiz, L
Schmit, JC
Schneider, F
Schoolmeester, A
Schuurman, R
Stellbrink, HJ
Stuyver, L
Van Lunzen, J
Van Remoortel, B
Van Wijngaerden, E
Vella, S
Witvrouw, M
Yerly, S
De Clercq, E
Desmyter, J
Vandamme, AM
Citation: K. Van Vaerenbergh et al., Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analogues, ANTIM AG CH, 44(8), 2000, pp. 2109-2117
Authors:
Stuyver, L
De Gendt, S
Van Geyt, C
Zoulim, F
Fried, M
Schinazi, RF
Rossau, R
Citation: L. Stuyver et al., A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness, J GEN VIROL, 81, 2000, pp. 67-74
Authors:
Lunel, F
Cadranel, JF
Rosenheim, M
Dorent, R
Di-Martino, V
Payan, C
Fretz, C
Ghoussoub, JJ
Bernard, B
Dumont, B
Perrin, M
Gandjbachkh, I
Huraux, JM
Stuyver, L
Opolon, P
Citation: F. Lunel et al., Hepatitis virus infections in heart transplant recipients: Epidemiology, natural history, characteristics, and impact on survival, GASTROENTY, 119(4), 2000, pp. 1064-1074
Authors:
Stuyver, L
Wyseur, A
Verpooten, G
Rossau, R
Citation: L. Stuyver et al., Line probe assay for detecting mutations in HIV-1 reverse transcriptase, METH MOL M, 24, 2000, pp. 259-267
Authors:
Van Laethem, K
Van Vaerenbergh, K
Schmit, JC
Sprecher, S
Hermans, P
De Vroey, V
Schuurman, R
Harrer, T
Witvrouw, M
Van Wijngaerden, E
Stuyver, L
Van Ranst, M
Desmyter, J
De Clercq, E
Vandamme, AM
Citation: K. Van Laethem et al., Phenotypic assays and sequencing are less sensitive than point mutation assays for detection of resistance in mixed HIV-1 genotypic populations, J ACQ IMM D, 22(2), 1999, pp. 107-118
Authors:
Stuyver, L
De Gendt, S
Cadranel, JF
Van Geyt, C
Van Reybroeck, G
Dorent, R
Gandjbachkh, I
Rosenheim, M
Charlotte, F
Opolon, P
Huraux, JM
Lunel, F
Citation: L. Stuyver et al., Three cases of severe subfulminant hepatitis in heart-transplanted patients after nosocomial transmission of a mutant hepatitis B virus, HEPATOLOGY, 29(6), 1999, pp. 1876-1883
Authors:
Teles, SA
Martins, RMB
Vanderborght, B
Stuyver, L
Gaspar, AMC
Yoshida, CFT
Citation: Sa. Teles et al., Hepatitis B virus: Genotypes and subtypes in Brazilian hemodialysis patients, ARTIF ORGAN, 23(12), 1999, pp. 1074-1078
Authors:
Brindeiro, R
Vanderborght, B
Caride, E
Correa, L
Oravec, RM
Berro, O
Stuyver, L
Tanuri, A
Citation: R. Brindeiro et al., Sequence diversity of the reverse transcriptase of human immunodeficiency virus type 1 from untreated Brazilian individuals, ANTIM AG CH, 43(7), 1999, pp. 1674-1680
Authors:
Robertson, B
Myers, G
Howard, C
Brettin, T
Bukh, J
Gaschen, B
Gojobori, T
Maertens, G
Mizokami, M
Nainan, O
Netesov, S
Nishioka, K
Shin-i, T
Simmonds, P
Smith, D
Stuyver, L
Weiner, A
Citation: B. Robertson et al., Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization, ARCH VIROL, 143(12), 1998, pp. 2493-2503
Authors:
Alvarado-Esquivel, C
Wyseur, A
Herrera-Ortiz, FD
Ruiz-Maya, L
Ruiz-Astorga, R
Zarate-Aguilar, A
Carrillo-Maravilla, E
Herrera-Luna, R
Morales-Macedo, MD
Maertens, G
Stuyver, L
Citation: C. Alvarado-esquivel et al., Hepatitis B and C virus infections in Mexico: genotypes and geographical distribution in blood donors and patients with liver disease, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 35-41
Authors:
Van Geyt, C
De Gendt, S
Rombout, A
Wyseur, A
Maertens, G
Rossau, R
Stuyver, L
Citation: C. Van Geyt et al., A line probe assay for hepatitis B virus genotypes, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 139-145
Authors:
Stuyver, L
Fretz, C
Maertens, G
Citation: L. Stuyver et al., Strategy for hepatitis C virus genotyping in epidemiological studies, HEPATITIS C VIRUS: GENETIC HETEROGENEITY AND VIRAL LOAD, 1997, pp. 45-51
Authors:
Lunel, F
Poinsot, H
Bogard, M
Brechot, C
Defer, C
Duverlie, G
Fouqueray, B
Halfon, P
Lewine, P
Loiseau, P
Marcellin, P
Zarski, JP
Stuyver, L
Citation: F. Lunel et al., Prevalence and characteristics of genotype 2 subtypes in France, HEPATITIS C VIRUS: GENETIC HETEROGENEITY AND VIRAL LOAD, 1997, pp. 111-114
Authors:
Khorsi, H
Stuyver, L
Castelain, S
Wyseur, A
Izopet, J
Capron, D
Capron, JP
Duverlie, G
Citation: H. Khorsi et al., Response to interferon and mutations in the NS5A gene in HCV-1b infection:preliminary study of the ISDR of French patients, HEPATITIS C VIRUS: GENETIC HETEROGENEITY AND VIRAL LOAD, 1997, pp. 133-136
Risultati:
1-23
|